화학공학소재연구정보센터
홈 로그인 로그아웃 연락처 사이트맵
Macromolecular Research, Vol.18, No.6, 602-609, June, 2010
DOI10.1007/s13233-010-0615-9  Export Citation
Macromolecules Isolated from Phellinus pini Fruiting Body: Chemical Characterization and Antiviral Activity
Sae Mi Lee, Sung Min Kim, Yoon Hee Lee, Woo Jung Kim, Jae Kweon Park, Yong Il Park†, Won Jong Jang1, Hyeon-Dong Shin2, and Andriy Synytsya3
  • Department of Biotechnology, The Catholic University of Korea, Gyeonggi-do, 420-743, Korea
  • 1Department of Microbiology, College of Medicine, Kon-Kuk University, Seoul, 143-701, Korea
  • 2Department of Environmental Science and Ecological Engineering, Korea University, Seoul, 136-701, Korea
  • 3Department of Carbohydrate Chemistry and Technology, Institute of Chemical Technology in Prague, Technicka 5, 166 28, Prague 6, Czech Republic
E-mail:
Two major polymers, EP-AV1 and EP-AV2, were purified from the hot-water extract of the Porodaedalea pini (Brot.) Murrill (syn. Phellinus pini) fruiting body by 75% ethanol precipitation and size-exclusion chromatography. These polymers were shown to be polysaccharides consisting of glucose as the main sugar residue as well as other minor sugars, such as galactose, xylose and mannose, and are variants of β-1,3-glucans, with high molecular masses, 1,006 and 100 kDa, respectively. Fourier-transform infrared and elemental analysis suggested that these polymers contained certain level (~10% in dry mass) of phenolic compounds. Both polymers inhibited plaque formation in Vero cells caused by herpes simplex virus 1 (HSV-1) by 91% and 93% at 5 g/mL, and by the coxsackie virus B3 (CVB3) in HeLa cells by 32% and 84% at 1 mg/mL, respectively. On the other hand, their cytotoxicity to both cells was negligible. Their selectivity indices (ratio CC50/EC50) against the HSV-1 virus were quite high, >25,000 (EP-AV1) and >16,670 (EPAV2), respectively. These polysaccharides also inhibited the neuraminidase activity in a dose-dependent manner but only at relatively higher concentrations. These results suggest that these water-soluble polysaccharides are promising agents for the treatment of HSV-1 infections.
Keywords:Phellinus pini;polysaccharides;purification;antiviral activity;β-1,3-glucan
  1. Bohn JA, BeMiller JN, Carbohydr. Polym., 28, 3 (1995)
  2. Berteau O, Mulloy B, Glycobiol., 13, 29R (2003)
  3. Coviello T, Palleschi A, Matricardi P, Bocchinfuso G, Alhaique F, Molecules, 10, 6 (2005)
  4. Mano JF, Silva GA, Azevedo HS, Malafaya PB, Sousa RA, Silva SS, Boesel LF, Oliveira JM, Santos TC, Marques AP, Neves NM, Reis RL, J. R. Soc. Interface, 4, 999 (2007)
  5. Zhang M, Cui SW, Cheung PCK, Wang Q, Trends Food Sci. Technol., 18, 4 (2007)
  6. Kim SK, Ravichandran YD, Khan SB, Kim YT, Biotechnol. Bioeng., 13, 511 (2008)
  7. Place ES, Evans ND, Stevens MM, Nat. Mater., 8(6), 457 (2009)
  8. Kang KS, Kim ID, Kwon RH, Ha BJ, Biotechnol. Bioeng., 13, 168 (2008)
  9. Kim WJ, Kim SM, Kim HG, Oh HR, Lee KB, Lee YK, Park YI, Algae, 22, 247 (2007)
  10. Fitton JH, Irhimeh M, Falk N, Cosmet. Toil., 122, 55 (2007)
  11. Yermak IM, Khotimchenko YS, Russian J. Mar. Biol., 23, 109 (1997)
  12. Cabello-Pasini A, Victoria-Cota N, Macias-Carranza V, Hernandez-Garibay E, Muniz-Salazar R, Am. J. Enol. Vitic., 56, 52 (2005)
  13. Lee CM, Jeong HJ, Kim DW, Lee KY, Macromol. Res., 16(5), 429 (2008)
  14. Kurita K, Mar. Biotechnol., 8, 203 (2006)
  15. Lee KY, Macromol. Res., 15(3), 195 (2007)
  16. Paterson RM, Phytochem., 67, 1985 (2006)
  17. Mastromarino P, Petruzziello R, Macchia S, Rieti S, Nicoletti R, Orsi N, J. Antimicrob. Chemoter., 39, 339 (1997)
  18. Pretus HA, Ensley HE, McNamee RB, Jones EJ, Browder IW, Williams DL, J. Pharm. Exp. Ther., 257, 500 (1991)
  19. Halleck FE, US Patent 3,447,940 (1969).
  20. Pirri R, Gadioux J, Rivenq R, Eur. Patent 484, 217 (1992).
  21. Halleck FE, US Patent 3,659,025 (1972).
  22. Duc ANC, Eur. Patent 45, 338 (1982).
  23. Farwick M, Maczkiewitz U, Mecking M, Schick G, Wollenweber U, US Patent 275, 239 (2006).
  24. Nystroem C, Fransen N, Bjoerk E, Patent WO 2006/085101 (2006).
  25. Sheth P, Lachman L, Fr. Patent 1,480,874 (1967).
  26. Brandt CR, Piraino F, Recent Res. Dev. Antimicrob. Agents Chemother., 4, 11 (2000).
  27. Eo SK, Kim YS, Oh KW, Lee CK, Lee YN, Han SS, Arch. Pharm. Res., 24, 74 (2001)
  28. Muller WEG, Weiler BE, Charubala R, Piferiderer W, Lserman L, Sobol RW, Suhadolnik J, Schroder HC, Biochem., 30, 2027 (1990)
  29. Tachedjian G, Tyssen D, Jardine D, Locarnini S, Birch C, Antiv. Chem. Chemother., 3, 183 (1992)
  30. Okumura A, Kubota T, Kato T, Morishima T, Pediatr. Infect. Dis. J., 25, 572 (2006)
  31. Coen D, Antiv. Res., 15, 287 (1991)
  32. Tisdale M, Rev. Med. Virol., 10, 45 (2000)
  33. Bartholomeusz A, Locarnini S, J. Med. Virol., 78, S52 (2006)
  34. Chang ST, Miles PG, Mycologist, 6, 64 (1992)
  35. Liu Y, Wang F, Carbohydr. Polym., 70, 386 (2007)
  36. Li G, Kim DH, Kim TD, Park BJ, Park HD, Park JI, Na MK, Kim HC, Hong ND, Lim K, Hwang BD, Yoon WH, Cancer Lett., 216, 175 (2004)
  37. Kim GY, Choi GS, Lee SH, Park YM, J. Ethnopham., 95, 69 (2004)
  38. Ikegawa T, Najanishi M, Uehara N, Chihara G, Fukuoka F, Jpn. J. Cancer Res., 59, 155 (1968)
  39. Jeong SC, Cho SP, Yang BK, Jeong YT, Ra KS, Song CH, J. Microbiol. Biotechnol., 14, 15 (2004)
  40. Yang BK, Park JB, Song CH, J. Microbiol. Biotechnol., 12, 957 (2002)
  41. Eichelberger MC, Hassantoufighi A, Wu M, Li M, Virol. J., 5, 109 (2008)
  42. Lee SM, Kim SM, Lee YH, Kim WJ, Na YS, Kim HG, Nam JH, Shin HD, Kwon DH, Park YI, J. Microbiol. Biotechnol., 37, 33 (2009)
  43. Dubois M, Gilles KA, Hamilton JK, Rebersand PA, Smith F, Anal. Chem., 28, 350 (1956)
  44. Bradford MM, Anal. Biochem., 72, 248 (1976)
  45. Scubiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR, Cancer Res., 48, 4827 (1988)
  46. Shigeta S, Mori S, Baba M, Ito M, Honzumi K, Nakamura K, Oshitani H, Numazaki Y, Matsuda A, Obara T, Shuto S, De Clercq E, Antimicrob. Agents Chemother., 36, 435 (1992)
  47. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB, Anal. Biochem., 94, 287 (1979)
  48. Honda S, Akao E, Suzuki S, Okuda M, Kakehi K, Nakamura J, Anal. Biochem., 180, 351 (1989)
  49. Amerine MA, Ough CS, Method analysis of musts and wine, Wiley & Sons, Chichester, 1980, pp 176-180.
  50. De S.F-Tischer PC, Talarico LB, Noseda MD, Guimaraes SMPB, Damonte EB, Duarte MER, Carbohydr. Polym., 63, 459 (2006)
  51. Lee JB, Hayashi K, Hashimoto M, Nakano T, Hayashi T, Chem. Pharm. Bull., 52, 1091 (2004)
  52. Zhang GL, Wang YH, Ni W, Teng HL, Lin ZB, World J. Gastroenterol., 8, 728 (2002)
  53. Baba M, Snoeck R, Pauwels R, De Clercq E, Antimicrob. Agents Chemother., 32, 1742 (1988)
  54. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM, Nat. Med., 3, 866 (1997)
  55. WuDunn D, Spear PG, J. Virol., 63, 52 (1989)
  56. Shannon WM, in Antiviral agents and viral diseases of man, Glasso GJ, Merigan TC, Buchanon RA, ed., Raven Press, New York, 1984, pp 55-121.